v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A, as filed with the SEC on September 30, 2025. The accompanying condensed balance sheet as of June 30, 2025 has been derived from the audited financial statements included in the Form 10-K/A. The interim results for the three and nine-months ended March 31, 2026 are not necessarily indicative of the results to be expected for the year ending June 30, 2026 or for any future periods.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Impairment of Long-lived and Intangible Assets

 

The Company had no impairment charges during the three and nine-month periods ended March 31, 2026 and 2025.

 

Net (Loss) Income per Common Stock

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per share of Common Stock is computed by dividing net (loss) income by the weighted average number of shares of Common Stock outstanding for the period.

 

The calculation of diluted net (loss) income per share does not consider the effect of the warrants issued and outstanding. For the three and nine-months ended March 31, 2026 and 2025, the calculation excludes the dilutive impact of warrants because none would be issued under the treasury method.

 

For the three-months ended March 31, 2026 and 2025, the dilutive shares were excluded as including them would be antidilutive.

 

For the nine-months ended March 31, 2026 and 2025, the convertible financial instrument and other share obligations were included in the dilutive calculation under the as converted method, as such the number of shares were included as if the shares were issued on July 1, 2025 and 2024, respectively and the interest expense and the change in fair value associated with the financial instruments was adjusted from net income to determine the numerator and denominator.

 

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2026

(Unaudited)

 

The following table reflects the calculation of basic net income (loss) per share of Common Stock (in dollars, except share amounts):

 

   Three Months Ended   Three Months Ended 
   March 31, 2026   March 31, 2025 
Basic and diluted net loss per Common Stock          
Numerator:          
Net loss  $(1,930,884)  $(2,902,828)
Denominator:          
Basic and diluted weighted average Common Stock outstanding   148,000,149    2,322,772 
Basic and diluted net loss per Common Stock  $(0.01)  $(1.25)

 

   Nine Months Ended   Nine Months Ended 
   March 31, 2026   March 31, 2025 
Basic net income per Common Stock          
Numerator:          
Net income  $4,412,993   $7,425,515 
Denominator:          
Basic weighted average Common Stock outstanding   116,647,478    975,727 
Basic net income per Common Stock  $0.04   $7.61 

 

The following table reflects the calculation of diluted net income (loss) per share of Common Stock (in dollars, except share amounts):

 

   Nine Months Ended-   Nine Months Ended- 
   March 31, 2026   March 31, 2025 
Diluted net income per Common Stock          
Numerator:          
Net income  $4,412,993   $7,425,515 
Change in fair value of financial instruments   1,073,373    (13,979,733)
Interest on dilutive instruments   1,587,348    6,050,871 
Allocation of net income, as adjusted  $7,073,714   $(503,347)
Denominator:          
Dilutive weighted average Common Stock outstanding   116,647,478    975,727 
If converted shares   19,698,961     
Dilutive weighted average Common Stock outstanding   136,346,439    975,727 
Diluted net income per Common Stock  $0.05   $(0.52)

 

For the nine months ended March 31, 2025, the numerator is adjusted for the interest expenses and other components to include the effect of the convertible securities under the as converted method at the beginning of the period. The adjustment to the numerator resulted in a net loss position. As such, including the effect of convertible securities in a loss situation would make the loss per share smaller, which is misleading and considered antidilutive under U.S. GAAP.

 

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2026

(Unaudited)

 

Below is a summary of the potentially dilutive instruments as of March 31, 2026 and 2025:

 

Description  March 31, 2026   March 31, 2025 
Sellers Notes       13,214,028 
Convertible notes - Chardan       1,594,763 
Secured convertible note   14,169,724    11,333,505 
Winston & Strawn agreement       1,034,381 
Tau agreement       888,973 
Debenture   3,555,553     
Unissued Stock Based compensation shares   1,973,684     
Promissory note       6,040 
Total Shares issuable under Convertible Note obligations – if converted total dilutive   19,698,961    28,071,690 
           
Public Warrants   10,062,500    10,062,500 
Private Warrants   5,553,125    5,553,125 
2025 Warrants   16,258,332     
Secured convertible note warrants   600,000    600,000 
Total excluded under treasury method – out of the money   32,473,957    16,215,625 

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal Deposit Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. The Company’s cash is deposited at five financial institutions. At March 31, 2026, the Company had $39,061,867 in excess of the FDIC limit.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for warrant liabilities, convertible notes derivative liability and the earnout liability (see Note 13).

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

 

Leases

 

The Company leases office space under operating lease arrangements. At lease commencement, the Company recognizes right of use assets and lease liabilities based on the present value of lease payments over the lease term. Because the Company’s leases do not provide an implicit interest rate, management uses the Company’s incremental borrowing rate at lease commencement. Lease expense is recognized on a straight line basis over the lease term.

 

Recent Accounting Standards

 

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

 

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2026

(Unaudited)